Assessment of gestational age in the high-risk newborns

1980 ◽  
Vol 47 (1) ◽  
pp. 65-67 ◽  
Author(s):  
O. N. Bhakoo
Keyword(s):  
2010 ◽  
Vol 30 (1) ◽  
pp. 58-73 ◽  
Author(s):  
Paul T. Seed ◽  
Lucy C. Chappell ◽  
Michael A. Black ◽  
Katrina K. Poppe ◽  
Yuan-Chun Hwang ◽  
...  

2014 ◽  
Vol 33 (9) ◽  
pp. 1033-1045 ◽  
Author(s):  
Heather J. Cole-Lewis ◽  
Trace S. Kershaw ◽  
Valerie A. Earnshaw ◽  
Kimberly Ann Yonkers ◽  
Haiqun Lin ◽  
...  

Author(s):  
Ramkanwar Deora ◽  
Nikhila Gara

Background: To investigate the diagnostic value of MCA/UA pulsatility index ratio for the prediction of adverse perinatal outcome in patients with high risk pregnancy.Methods: We included in the study 170 patients recovered in our hospital with the diagnosis of preeclampsia and gestational hypertension, twins, postdated, IUGR, BOH from June 2016 to May 2017. All the patients underwent accurate color Doppler velocimetry examination available in our hospital. Outcome variables were intrauterine and early neonatal death, admission to neonatal intensive care unit and the duration of treatment, APGAR score below 7 at 5 minutes, cesarean delivery for foetal distress, gestational age at delivery, neonatal birth weight, IUGR.Results: In 102 patients, we found abnormal values of CPI ratio. Neonates of mothers with abnormal CPI ratio had significantly lower gestational age at delivery, lower birth weight, significantly greater risk for perinatal death, significantly greater risk of admission to intensive care unit, longer duration of treatment in NICU, greater rate of cesarean delivery for foetal distress, increased number of fetuses IUGR.Conclusions: CPI ratio is a very good predictor of adverse outcome in the fetuses of women with pre-eclampsia and other high-risk pregnancy.


Author(s):  
Vidyashree G. Poojari ◽  
Arevidya Reddy ◽  
Akhila Vasudeva

Background: Congenital heart defects (CHD) remain the most prevalent congenital malformations, with an estimated prevalence of 6-8 per 1000 live births. Routinely, fetal echo is performed around 18-22 weeks among high risk cases. A dedicated early fetal echo (EFEC) performed by experts between 11-16 weeks is emerging as an excellent screening tool among high risk cases. However, feasibility of obtaining such cardiac views during routine Nuchal Translucency scan by trained obstetricians, is yet to be known as there is limited time available with high patient turn over. Present study aimed to know the feasibility and accuracy of EFEC in unselected obstetric population in a tertiary maternity centre with high patient turnover.Methods: This was an observational cohort study from March 2015 to April 2017 at a tertiary maternity referral hospital. Singleton pregnant women undergoing routine 11-13+6 weeks scanning (NT scan) were recruited in the study including both high and low risk pregnancies. Possibility of obtaining 4 basic cardiac views within this limited time was assessed.Results: A total of 180 early fetal ECHO’s were performed during the course of this study. The 4-chamber view (79.44%) of the heart was the easiest parameter to visualize. RVOT (28.88%) was the most difficult view to be obtained. Complete visualization of all the cardiac views was possible in only 34 women (18.88%). The visualization rates of the cardiac views improved as the gestational age increased. TVS was essential to obtain cardiac views in 5 cases out of 138 (3.6%) in 12-13+6 scans. Whereas, TVS was essential to visualize cardiac views in 34 cases out of 42 (80.95%) between 11 weeks to 11 weeks 6 days. A total of 7 cardiac anomalies were detected during this study. There were 3 major and 4 minor cardiac malformations. Out of the 3 major anomalies, 2 were AVSDs which were diagnosed by EFEC. Minor defects were undetected.Conclusions: It is feasible to get the basic cardiac views in the limited time available to perform NT scan among unselected obstetric population in a tertiary maternity centre with a high turnover. Gestational age of 12 weeks and above seems to increase the accuracy. TVS is a useful adjunct throughout 11-14 weeks scan.


PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0247782
Author(s):  
Rachel Van Doorn ◽  
Narmin Mukhtarova ◽  
Ian P. Flyke ◽  
Michael Lasarev ◽  
KyungMann Kim ◽  
...  

Objective To evaluate the effect of aspirin dose on the incidence of all gestational age preeclampsia and preterm preeclampsia. Data sources Electronic databases (Cochrane, PubMed, Scopus, ClinicalTrials.gov and the Web of Science) were searched for articles published between January 1985 and March 2019 with no language restrictions. Methods We followed the PRIMSA guidelines and utilized Covidence software. Articles were screened by 2 independent reviewers, with discrepancies settled by an independent 3rd party. Study selection criteria were randomized trials comparing aspirin for prevention of all gestational age and preterm preeclampsia to placebo or no antiplatelet treatment in women aged 15–55 years with moderate or high-risk factors according to the list of risk factors from American College of Obstetricians and Gynecologists and United States Preventive Services Task Force guidelines. The quality of trials was assessed using the Cochrane risk of bias tool. The data were pooled using a random-effects meta-analysis comparing aspirin at doses of <81, 81, 100, and 150 mg. Pre-specified outcomes were all gestational age and preterm preeclampsia. Results Of 1,609 articles screened, 23 randomized trials, which included 32,370 women, fulfilled the inclusion criteria. In preterm preeclampsia, women assigned at random to 150 mg experienced a significant 62% reduction in risk of preterm preeclampsia (RR = 0.38; 95% CI: 0.20–0.72; P = 0.011). Aspirin doses <150 mg produced no significant reductions. The number needed to treat with 150 mg of aspirin was 39 (95% CI: 23–100). There was a maximum 30% reduction in risk of all gestational age preeclampsia at all aspirin doses. Conclusions In this meta-analysis, based on indirect comparisons, aspirin at a dose greater than the current, recommended 81 mg was associated with the highest reduction in preterm preeclampsia. Our meta-analysis is limited due to the deficiency of homogeneous high evidence data available in the literature to date; however, it may be prudent for clinicians to consider that the optimal aspirin dose may be higher than the current guidelines advise. Future research to compare the efficacy aspirin doses greater than 81 mg is recommended. Study registration PROSPERO, CRD42019127951 (University of York, UK; http://www.crd.york.ac.uk/PROSPERO/).


2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Baoying Ye ◽  
Yi Wu ◽  
Jiong Chen ◽  
Yu Yang ◽  
Jianmei Niu ◽  
...  

2019 ◽  
Vol 47 (9) ◽  
pp. 4365-4373
Author(s):  
HW Kang ◽  
WY Kim ◽  
SJ Jin ◽  
YH Kim ◽  
TJ Min ◽  
...  

Objective The number of high-risk pregnancies is increasing in tertiary medical centers. Therefore, we investigated perioperative outcomes based on risk factors to ascertain proper maternal and neonatal management. Methods We reviewed the medical records of patients receiving cesarean sections over an 8-year period. Clinical parameters for anesthesia and the neonatal outcome were compared among high-risk groups after subdivision by the number of clinical risk factors. The groups were as follows: group A (one risk factor), group B (two risk factors), and group C (three or more risk factors). Results Patient age, estimated blood loss (EBL), and volume of transfused red blood cell (RBC) were higher in group B than group A. Birth weight, 1- and 5-minute Apgar scores, and gestational age were lower while the frequency of neonatal intensive care unit (NICU) admission was higher in group B than group A. Group C patients were significantly older than group A or B patients. Birth weight, 1- and 5-minute Apgar scores and gestational age were significantly lower while frequency of NICU admission was higher in group C than group A and B. Conclusion The number of maternal risk factors was positively associated with adverse outcomes in the neonates.


Sign in / Sign up

Export Citation Format

Share Document